Institute of Pharmaceutics, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Institute of Pharmaceutics, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
J Control Release. 2020 Sep 10;325:223-234. doi: 10.1016/j.jconrel.2020.06.037. Epub 2020 Jul 3.
As the main cause of tumoral fatality, metastasis remains to be one of the most urgent difficulties researcher struggled to overcome. During the development and progression of metastasis, the establishment of pre-metastatic niche is crucial in preparing fertile microenvironment for disseminated tumor cells settlement and colonization in distant metastatic target sites. The key participators, including the primary tumor-derived factors, bone marrow-derived cells, stromal cells of both the host and the potential metastatic sites, regulate the temporal progress of potential metastasis. Firstly, pioneers are sent from primary tumor, recruiting immunosuppressive cells; then circulating tumor cells settled and colonized; and finally, micrometastases develop. Here, we summarize the therapeutic strategies presented in recent years targeting different stages of the pre-metastatic niche formation and discuss their chances and challenges in clinical translation, providing promising approaches for metastasis prevention and therapeutic interventions.
作为肿瘤致死的主要原因,转移仍然是研究人员努力克服的最紧迫的难题之一。在转移的发展和进展过程中,前转移小生境的建立对于为播散的肿瘤细胞在远处转移靶部位定居和殖民化准备肥沃的微环境至关重要。包括原发性肿瘤衍生因子、骨髓来源细胞、宿主和潜在转移部位的基质细胞在内的关键参与者,调节着潜在转移的时间进展。首先,先驱者从原发性肿瘤中派出,招募免疫抑制细胞;然后循环肿瘤细胞定居和殖民化;最后,微转移发展。在这里,我们总结了近年来针对前转移小生境形成不同阶段的治疗策略,并讨论了它们在临床转化中的机会和挑战,为转移的预防和治疗干预提供了有前途的方法。